Hosted on MSN23d
Charles River falls after projecting 2025 revenue dropCharles River Laboratories (NYSE:CRL) lost ~12% in the premarket on Tuesday after the contract research organization said its 2025 revenue on an organic basis is expected to decline at a similar ...
In a report released on February 1, Casey Woodring from J.P. Morgan maintained a Hold rating on Charles River Labs (CRL – Research Report), ...
CRAI, as a relatively small player in the consulting and research services sector, presents a compelling narrative when evaluating its market position and growth potential. The company has carved ...
OptimX Markets has moved to expand its ability to offer institutional clients bilateral liquidity with a new integration with State Street’s order and execution platform, Charles River. As part of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results